1999•Hospital MedicineRequires access

Use of apomorphine in Parkinson's disease

John D. O’Sullivan, Andrew John Lees

Open publisher page 23 citations

Abstract

Apomorphine is a dopamine agonist administered subcutaneously as intermittent injections or in a continuous infusion. It is useful in managing advanced Parkinson's disease, and provides an alternative to neurosurgical procedures. This review summarizes indications and practical guidelines for its use.

About this research paper

What this paper is about

Apomorphine is a dopamine agonist administered subcutaneously as intermittent injections or in a continuous infusion. It is useful in managing advanced Parkinson's disease, and provides an alternative to neurosurgical procedures. This review summarizes indications and practical guidelines for its use.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Apomorphine is a dopamine agonist administered subcutaneously as intermittent injections or in a continuous infusion. It is useful in managing advanced Parkinson's disease, and provides an alternative to neurosurgical procedures. This review summarizes indications and practical guidelines for its use.

Key concepts: Apomorphine, Medicine, Parkinson's disease, Dopamine agonist, Dopamine, Disease, Agonist, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Use of apomorphine in Parkinson's disease — Research Paper | ScholarLens